A Study Measuring the Effectiveness, Safety, and Tolerability of BMS-986278 in Participants With Lung Fibrosis
Clinical trial NCT04308681 · COMPLETED
Trial details
- NCT number
- NCT04308681
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-29
- Primary completion
- 2022-08-04
- Enrollment
- 403
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.